WELL Health: Is Time Running Out to Buy this Stock Cheap?

WELL Health stock just reported yet another quarter where it beat analyst expectations and raised its guidance.

| More on:
healthcare pharma

Image source: Getty Images

Throughout the year, there have been many opportunities for investors to buy high-quality, high-potential Canadian stocks while they trade undervalued. And without a doubt, one of the best stocks to consider while it’s still so cheap is WELL Health Technologies (TSX:WELL).

WELL stock has had an interesting journey over the last couple of years. Because it owns and operates several telehealth apps and digital health businesses, it saw a massive rally during the pandemic. However, it also saw a significant selloff after the pandemic as investors were concerned that growth might slow. WELL also got caught up in the broader market selloff throughout 2022, which has caused the stock to become unbelievably cheap.

Despite this undervalued share price, WELL continues to beat expectations every time it reports earnings. For the second time already, it also recently increased its guidance for the full year, and we’re only through the second quarter.

So let’s look at how impressive WELL Health stock has been recently and just how undervalued the stock is today.

WELL Health stock crushes earnings

In recent quarters over the last two years, WELL has consistently beaten analysts’ expectations and is constantly raising its forward guidance. And in the second quarter of 2022, it was more of the same for this high-potential growth stock.

WELL’s revenue not only beat expectations by nearly 8% ($140 million vs $130 million estimated), but that was also up a whopping 127% year-over-year. WELL Health stock has long been growing mainly by acquisition, but it’s also achieved impressive organic growth, especially as of late. Of that 127% gain in revenue, 20% came from organic growth, an incredibly impressive number.

That doesn’t even come close to all of the positive news from WELL’s earnings report. The stock’s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also beat expectations significantly, coming in at $26.4 million for the quarter, 17% higher than analyst expectations.

Furthermore, it continued to achieve a record number of omnichannel patient visits with over 830,000 in the quarter, an increase of 49% year-over-year.

This led to another increase in its full-year guidance, with the company now expecting to achieve over $550 million in revenue for the full year. It also now expects to generate adjusted EBITDA of roughly $100 million and anticipates positive net earnings for the full year.

So with WELL Health stock still trading at some of the cheapest levels it’s ever been, there’s no question that it’s an incredible opportunity.

One of the best value stocks on the market

With WELL Health stock trading at around $4 per share, the stock is down just under 50% over the last year. However, while the stock has lost about half of its value in the last 12 months, its sales have more than doubled, with revenue up 127% year-over-year.

WELL Health Stock

So, with the stock trading at a forward enterprise value (EV) to EBITDA ratio of just 12.3 times, there’s no question that this stock offers an incredible opportunity. Not only is WELL stock ultra-cheap for a high-potential growth stock, it’s also much cheaper than it’s historical average since going public on the TSX just prior to the pandemic.

WELL is even trading below its one-year average of 15 times. A year ago, when the stock was roughly double the price, WELL had a forward EV to EBITDA ratio of 22 times.

Now is a great time to buy WELL stock while it’s still so undervalued. It’s only a matter of time before this high-potential, and highly consistent growth stock comes back into favour, so this is an opportunity you won’t want to miss.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has positions in WELL Health Technologies Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

Better Artificial Intelligence Stock: UiPath vs. C3.ai

Deciding between UiPath and C3.ai isn't easy since both have strengths and weaknesses.

Read more »

data analyze research
Investing

The 1 Stock to Own in a Sideways Economy

Here's why Restaurant Brands (TSX:QSR) remains a top TSX stock investors shouldn't ignore for long-term gains in this market.

Read more »

Retirees sip their morning coffee outside.
Retirement

Here’s the Average RRSP Balance at Age 65 and 71 in Canada

Canadian investors can consider holding dividend stocks and supplement their CPP and RRSP payouts in retirement.

Read more »

Technology
Dividend Stocks

10 Years From Now, You’ll Be Glad You Bought These Magnificent TSX Dividend Stocks

The TSX is lucrative to buy these magnificent dividend stocks in bulk and be proud of this decision 10 years…

Read more »

sale discount best price
Energy Stocks

Time to Pounce: 1 Phenomenal TSX Stock That Hasn’t Been This Cheap in a While

Now could be the time to get into Cameco (TSX:CCO) stock, which is up 81% in the last year but…

Read more »

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

3 Millionaire-Maker Tech Stocks That Should Be on Your Radar

These three tech stocks have already proven themselves worthy, but have a lot more to prove in the near future.…

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

calculate and analyze stock
Dividend Stocks

4 Fabulous Dividend Stocks to Buy in July

Are you looking for long-term income? These four dividend stocks should not only provide you with value in July but…

Read more »